CS801886A2 - Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production - Google Patents

Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production

Info

Publication number
CS801886A2
CS801886A2 CS868018A CS801886A CS801886A2 CS 801886 A2 CS801886 A2 CS 801886A2 CS 868018 A CS868018 A CS 868018A CS 801886 A CS801886 A CS 801886A CS 801886 A2 CS801886 A2 CS 801886A2
Authority
CS
Czechoslovakia
Prior art keywords
opt
alkyl
substd
alkoxy
etherified
Prior art date
Application number
CS868018A
Other languages
Czech (cs)
Other versions
CS268684B2 (en
Inventor
Leslie J Dr Browne
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/622,421 external-priority patent/US4617307A/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Priority to CS868018A priority Critical patent/CS268684B2/en
Publication of CS801886A2 publication Critical patent/CS801886A2/en
Publication of CS268684B2 publication Critical patent/CS268684B2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

(A) Bicyclic imidazole derivs. of formula (Ia)-(Ic) and their salts are new. R1=H; alkyl opt. substd. by alkanoyl, NH2, mono- or dialkylamino, SO3H, COOH, alkoxycarbonyl, CONH2 or CN; 2-7C alkyl substd. by OH, alkoxy, halogen or alkanoyloxy; NO2, alkoxy, alkanoyl alkanoyloxy, phenylsulphonyloxy, alkylsulphonyloxy, alkylthio, alkylsulphinyl, alkylsulphonyl, alkanoylthio, NH2, mono- or dialkylamino, alkylenamino, morpholino, thiomorpholino, 1-piperazinyl, 4-alkyl-1-piperazinyl, trialkylammonio, SO3H, alkoxy sulphonyl, SO2NH2, mono- or dialkylsulphamoyl; iminomethyl opt. N-substd. by OH, alkoxy, alkanoyloxy, alkyl, phenyl or NH2; 2-7C alkanoyl or benzoyl; R2=H, alkyl, phenylalkyl, carboxyalkyl, alkoxycarbonylalkyl, halogen, OH, alkoxy, alkanoyloxy, SH, alkylthio, phenylalkylthio, phenylthio, alkanoylthio, COOH, alkoxycarbonyl or alkanoyl; R'1=R1, CH2OH, alkoxymethyl, halomethyl, alkanoyloxymethyl, halogen, OH, SH, CHO, COOH, alkoxycarbonyl, CONH2, mono- or dialkylcarbamoyl, CN, 5-tetrazolyl, 4,5-dihydro-2-oxazolyl (opt. substd. by alkyl) or CONHOH, n=0-4; R''1 =R1 or may be R'1 when n=0, 1, 3 or 4 or when n=2 and R2=phenyl alkyl, carboxyalkyl, alkoxycarbonylalkyl, alkanoyloxy, SH, alkylthio, phenylalkylthio, phenylthio, alkanoylthio, COOH, alkoxycarbonyl or alkanoyl; all alkyl, alkoxy and alkanoyl gps. are 'lower' unless otherwise stated; all phenyl gps. are opt. substd. by alkyl, alkoxy or halogen. - (B) The use of cpds. (Ia, R1=R, R2=R') (Ib: R'1=R, R2=R') and (Ic; R''1=R1, R2=R') for prepn. of medicaments for treating diseases responding to aromatase inhibition is claimed, where: R= H, opt. substd. alkyl, NO2, halogen, opt. etherified or esterified OH, opt. etherified, oxidised-etherified or esterified SH, NH2, mono- or disubstd. amino, ammonio, opt. functionally modified SO3H, COOH or CHO or 2-20C acyl; R'=H, opt. substd. alkyl, halogen, opt. etherified or esterified OH, opt. etherified, oxidised-etherified or esterified SH, opt. functionally modi
CS868018A 1984-06-20 1986-11-05 Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production CS268684B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS868018A CS268684B2 (en) 1984-06-20 1986-11-05 Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/622,421 US4617307A (en) 1984-06-20 1984-06-20 Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
CS854449A CS268672B2 (en) 1984-06-20 1985-06-18 Method of substituted imidazo-(1,5-a)pyridine derivatives production
CS868018A CS268684B2 (en) 1984-06-20 1986-11-05 Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production

Publications (2)

Publication Number Publication Date
CS801886A2 true CS801886A2 (en) 1989-07-12
CS268684B2 CS268684B2 (en) 1990-04-11

Family

ID=25745999

Family Applications (3)

Application Number Title Priority Date Filing Date
CS868018A CS268684B2 (en) 1984-06-20 1986-11-05 Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
CS868019A CS268685B2 (en) 1984-06-20 1986-11-05 Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
CS868021A CS268687B2 (en) 1984-06-20 1986-11-05 Method of substituted imidazopyridine derivatives production

Family Applications After (2)

Application Number Title Priority Date Filing Date
CS868019A CS268685B2 (en) 1984-06-20 1986-11-05 Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
CS868021A CS268687B2 (en) 1984-06-20 1986-11-05 Method of substituted imidazopyridine derivatives production

Country Status (1)

Country Link
CS (3) CS268684B2 (en)

Also Published As

Publication number Publication date
CS268687B2 (en) 1990-04-11
CS802186A2 (en) 1989-07-12
CS801986A2 (en) 1989-07-12
CS268685B2 (en) 1990-04-11
CS268684B2 (en) 1990-04-11

Similar Documents

Publication Publication Date Title
SE8802815D0 (en) EPIPODOPHYLLOTOXIN GLUCOSIDE 4'-PHOSPHATE DERIVATIVES
HRP20010119B1 (en) Preventing airway mucus production by administration of egf-r antagonists
DK0585242T3 (en) Wound healing
TR200201052T2 (en) New class of cell differentiating agents and histone deacetylase inhibitors, and methods of use herein
LU90128I2 (en) Letrozole and its pharmaceutically acceptable salts and derivatives (Femara)
ES8609275A1 (en) New N-aryl or hetero-aryl-pyrimidine-2-amine(s)
Cassin et al. The effects of bumetanide and furosemide on lung liquid secretion in fetal sheep
CS801886A2 (en) Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
HK1025504A1 (en) Use of latency associated peptide for the manufacture of a medicament for increasing wound healing
CS802086A2 (en) Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
IS1549B (en) 1,4 - Dihydropyridines, and their method of manufacture as well as its therapeutic use
EA200100214A1 (en) APPLICATION OF DERIVATIVES OF CAMPTOTECINE WITH REDUCED GASTROINTESTINAL TOXICITY
FI953841A0 (en) Substituted quinoline derivatives, process for their preparation
ATE34661T1 (en) LIPID LEVEL REDUCING COMPOUNDS.
Tomono et al. Synergistic potentiating effects of choline phosphate and ethanolamine on insulin-induced DNA synthesis in NIH 3T3 fibroblasts
DK0533210T3 (en) Protein C-containing pharmaceutical preparations as agents for inflammation.
AU3818989A (en) The use of substituted 3,4-dihydro-2h-benzopyrans as remedies for constructive functional disorders of the lungs and/or disorders of the efferent urinary passages
Norris et al. Phenytoin-lnduced Gum Hypertrophy Improved by Isotretinoin.
FR2350101A1 (en) (4)-Amino-(6,7)-dimethoxy-piperidino or alkylene-diamino quinazolines - are antihypertensives with no undesirable side-effects
DE3889497D1 (en) 3,4-dihydro-2-alkyl-3-oxo-N-aryl-2H- [1] benzothieno [3,2-e] -1,2-thiazine-4-carboxamide-1,1-dioxide.
Pecoits-Filho et al. Roxadustat Treatment Results in Consistent Improvements in Hemoglobin (Hb) vs. Placebo: An Analysis of Three Multinational Randomized Clinical Trials in Patients with Non-Dialysis-Dependent CKD (NDD-CKD): TH-OR05
Pergola et al. Hemoglobin (Hb) Correction with Roxadustat Is Associated with Improved Iron Homeostasis in Patients with Dialysis-Dependent CKD (DD-CKD): TH-OR06
EP0209089A3 (en) Use of quinazolines in the preparation of a medicament for treating and preventing ischemic cardiac disease or arrhythmia
FR2307536A1 (en) 5-Sulphomoyl-anthranilic acid derivs - 4-substd. by piperazino, with hypotensive activity
ES8604556A1 (en) Flavene and thioflavene derivatives, processes for their manufacture, pharmaceutical preparations that contain such compounds, and the use of the latter.

Legal Events

Date Code Title Description
MK4A Patent expired

Effective date: 20000618